drug · antibody
osemitamab
Phase 2updated 3mo agoby Transcenta Holding Ltd🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.
indications
indications
NSCLCColorectal Cancer
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that